Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group.
Lindholm LH, et al. Among authors: julius s.
J Hypertens. 2002 Sep;20(9):1879-86. doi: 10.1097/00004872-200209000-00035.
J Hypertens. 2002.
PMID: 12195132
Clinical Trial.